Efficacy of Dehydroepiandrosterone to overcome the effect of ovarian aging - DHEA Intervention To Treat Ovarian aging

niversity of Nottingham0 个研究点目标入组 0 人开始时间: 2012年1月5日最近更新: 2015年8月4日

试验速览

暂无简介。

•1. Women aged =23 years with diminished ovarian reserve Antral follicle count of =10 or Anti-Mullerian hormone levels <5pmol/L 2. Women undergoing IVF/ICSI treatment 3. Women must have a regular spontaneous menstrual cycle of 21 – 35 days 4. Women must be willing and comply with scheduled visits, treatment plan and laboratory tests.
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 50
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range 0

•1. BMI >35 Kg/M2 2. Women with a single ovary 3. Untreated hydrosalpinx/ submucous fibroid/ Endometrial polyp at the start of treatment 4. Any history of seizure disorders 5. Previous participation in this trial in an earlier treatment cycle 6. Any known endocrine disorders such as congenital adrenal hyperplasia, thyroid diseases, hyperprolactinemia 7. Known allergy to DHEA 8. Diabetic women on insulin (Insulin lower the DHEA levels and might lower the effectiveness of DHEA supplements)

发起方

niversity of Nottingham